UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is Intravenous and Oral Topotecan in Small-Cell Lung Cancer Truly Equal? A Case Report

Case reports in oncology, 2024-10, Vol.17 (1), p.1140-1145

2024

Volltextzugriff (PDF)

Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications

Cancers, 2023-05, Vol.15 (10), p.2702

2023

Volltextzugriff (PDF)

Sjögren’s Syndrome Caused by PD-1 Inhibition in a Lung Cancer Patient

Case reports in oncology, 2023-01, Vol.16 (1), p.1095-1099

2023

Volltextzugriff (PDF)

Triple Trouble: A Case of Multiple Resistance Mechanisms after First Generation EGFR-TKI in NSCLC

Case reports in oncology, 2019-05, Vol.12 (2), p.625-630

2019

Volltextzugriff (PDF)

The path forward in early-stage lung cancer

Translational lung cancer research, 2023-01, Vol.12 (1), p.11-13

2023

Volltextzugriff (PDF)

Vaccination therapy for non-small-cell lung cancer

Current opinion in oncology, 2014-03, Vol.26 (2), p.165-170

2014

Volltextzugriff (PDF)

HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors

Lung cancer (Amsterdam, Netherlands), 2022-08, Vol.170, p.1-10

2022

Volltextzugriff (PDF)

Idiopathic pleuroparenchymatous fibroelastosis: A case report and brief review of the literature

Respiratory medicine case reports, 2014-01, Vol.12 (C), p.7-9

2014

Volltextzugriff (PDF)

Immune checkpoint inhibition in early-stage non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2024-07, Vol.193, p.107855, Article 107855

2024

Volltextzugriff (PDF)

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Journal of thoracic oncology, 2023-02, Vol.18 (2), p.169-180

2023

Volltextzugriff (PDF)

The Adenosinergic Pathway in Non-Small Cell Lung Cancer

Cancers, 2024-09, Vol.16 (18), p.3142

2024

Volltextzugriff (PDF)

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

Nature medicine, 2024-06, Vol.30 (6), p.1602-1611

2024

Volltextzugriff (PDF)

Surgical outcomes of patients with resectable non-small-cell lung cancer receiving neoadjuvant immunotherapy with nivolumab plus relatlimab or nivolumab: Findings from the prospective, randomized, multicentric phase II study NEOpredict-Lung

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8500-8500

2023

Volltextzugriff (PDF)

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Critical reviews in oncology/hematology, 2022-01, Vol.169, p.103564-103564, Article 103564

2022

Volltextzugriff (PDF)

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

Journal of thoracic oncology, 2023-12, Vol.18 (12), p.1731-1742

2023

Volltextzugriff (PDF)

A rare cause of recurrent hemopneumothorax

Acta clinica belgica (English ed. Online), 2020-06, Vol.75 (3), p.235-237

2020

Volltextzugriff (PDF)

Uncommon EGFR mutations on osimertinib, real-life data (UNICORN study): Updated results, brain efficacy, and resistance mechanisms

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9109-9109

2022

Volltextzugriff (PDF)

Case report 1: A case of failed posaconazole prophylaxis

Mycoses, 2010-07, Vol.53, p.3-5

2010

Volltextzugriff (PDF)

Characteristics and outcome of unplanned hospital admissions in patients with lung cancer: a longitudinal tertiary center study. Towards a strategy to reduce the burden

Supportive care in cancer, 2016-07, Vol.24 (7), p.2827-2835

2016

Volltextzugriff (PDF)

A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer

Acta oncologica, 2022-06, Vol.61 (6), p.773-776

2022

Volltextzugriff (PDF)

Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment

Journal of clinical medicine, 2022-03, Vol.11 (6), p.1738

2022

Volltextzugriff (PDF)

Abstract CT021: Preliminary clinical results of a therapeutic cancer vaccine PDClung01 in combination with anti-PD-1 in patients (pts) with stage IV NSCLC

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT021-CT021

2024

Volltextzugriff (PDF)

Abstract 1182: PDClung01: An innovative therapeutic cancer vaccine induces specific immune responses in combination with anti- PD-1 treatment in patients with non-small cell lung cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.1182-1182

2024

Volltextzugriff (PDF)

Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study

Drugs -- real world outcomes, 2021-06, Vol.8 (2), p.141-152

2021

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)
Berichte
(4)

Sprache

Englisch
(32)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Is Intravenous and Oral Topotecan in Small-Cell Lung Cancer Truly Equal? A Case Report

Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications

Sjögren’s Syndrome Caused by PD-1 Inhibition in a Lung Cancer Patient

Triple Trouble: A Case of Multiple Resistance Mechanisms after First Generation EGFR-TKI in NSCLC

The path forward in early-stage lung cancer

Vaccination therapy for non-small-cell lung cancer

HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors

Idiopathic pleuroparenchymatous fibroelastosis: A case report and brief review of the literature

Immune checkpoint inhibition in early-stage non-small cell lung cancer

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

The Adenosinergic Pathway in Non-Small Cell Lung Cancer

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

Surgical outcomes of patients with resectable non-small-cell lung cancer receiving neoadjuvant immunotherapy with nivolumab plus relatlimab or nivolumab: Findings from the prospective, randomized, multicentric phase II study NEOpredict-Lung

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial

A rare cause of recurrent hemopneumothorax

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR -Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

Uncommon EGFR mutations on osimertinib, real-life data (UNICORN study): Updated results, brain efficacy, and resistance mechanisms

Case report 1: A case of failed posaconazole prophylaxis

Characteristics and outcome of unplanned hospital admissions in patients with lung cancer: a longitudinal tertiary center study. Towards a strategy to reduce the burden

A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer

Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment

Abstract CT021: Preliminary clinical results of a therapeutic cancer vaccine PDClung01 in combination with anti-PD-1 in patients (pts) with stage IV NSCLC

Abstract 1182: PDClung01: An innovative therapeutic cancer vaccine induces specific immune responses in combination with anti- PD-1 treatment in patients with non-small cell lung cancer

Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study

Suchergebnisse filtern